Infantile Hemangioma Clinical Trial
Official title:
Nadolol for Proliferating Infantile Hemangiomas: A Prospective Open Label Study With a Historical Control
The purpose of this study is to explore the efficacy and safety of Nadolol in hemangiomas of infancy. The secondary objective is to assess the feasibility of conducting a randomized controlled trial comparing nadolol with corticosteroids and propranolol.
Systemic corticosteroids are currently the most frequent used medication for treatment of problematic infantile hemangiomas (IH's). Since June 2008, systemic propranolol has been an important addition to the therapeutic options for problematic IH, allowing decreased dependence on the systemic corticosteroids. So far, we have found excellent response with propranolol with minimal short-term side effects. Studies, which compared nadolol and propranolol in children with other conditions, suggest that nadolol is safer and more efficacious than propranolol. In addition, it has better dosing schedules and less central nervous system (CNS) penetration, making it suitable even for patients with suspected or proven PHACES syndrome. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02505971 -
Nadolol Versus Propranolol in Children With Infantile Hemangiomas
|
Phase 3 | |
| Recruiting |
NCT04288700 -
Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary Hemangioma
|
Phase 4 | |
| Completed |
NCT01431326 -
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
|
||
| Completed |
NCT02913612 -
Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)
|
Phase 2 | |
| Completed |
NCT01673971 -
Optical Tomographic Imaging of Infantile Hemangiomas
|
||
| Recruiting |
NCT03237637 -
Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas
|
Phase 3 | |
| Recruiting |
NCT05479123 -
Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas
|
Phase 4 | |
| Terminated |
NCT01434849 -
Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)
|
Phase 1 | |
| Completed |
NCT04105517 -
Hemangiol, Post Marketing Surveillance Study
|
||
| Completed |
NCT01512173 -
Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo
|
Phase 2 | |
| Completed |
NCT01056341 -
Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy
|
Phase 2/Phase 3 | |
| Not yet recruiting |
NCT04684667 -
''Efficacy of Propranolol in the Treatment of Infantile Hemangioma"
|
Phase 2 | |
| Recruiting |
NCT03842631 -
Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination
|
||
| Recruiting |
NCT03173352 -
A Prospective Study on the Incidence and Related Risk Factors of Infantile Hemangioma in China
|
N/A |